Altamira Therapeutics Provides Business Update and First Half 2023 Financial Results
Company hosts 1H 2023 Financial Results and Business Update call today at 8 a.m.
- Company hosts 1H 2023 Financial Results and Business Update call today at 8 a.m.
- ET
Altamira Therapeutics Ltd. (NASDAQ:CYTO) ("Altamira" or the "Company"), a company dedicated to addressing unmet medical needs, today provided a business update and reported its first half 2023 financial results. - Net loss for the first half of 2023 was CHF 5.4 million compared with CHF 8.2 million for the first half of 2022.
- ET to discuss its business update and first half 2023 results.